SCHEMBL5953353

SCHEMBL5953353

Cc1ccc(N(c2ccc(C)cc2)c2ccc(/C=C/c3ccc(N(c4ccc(C)cc4)c4ccc(C)cc4)cc3)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 4/20 0.56
RELA Q04206 2/20 0.52
ALOX5 P09917 1/20 0.48
PTGS1 P23219 1/20 0.48
PTGS2 P35354 1/20 0.48
CA1 P00915 1/20 0.46
ALDH1A1 P00352 1/20 0.46
TSHR P16473 1/20 0.46
APP P05067 3/20 0.45
MEN1 O00255 3/20 0.45
RAB9A P51151 3/20 0.45
KMT2A Q03164 3/20 0.45
APOBEC3A P31941 2/20 0.45
APOBEC3G Q9HC16 2/20 0.45
NPC1 O15118 2/20 0.44
GAA P10253 1/20 0.44
GFER P55789 1/20 0.44
CYP2A6 P11509 1/20 0.44
TUBB4A P04350 1/20 0.44
TUBB P07437 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5494929 1.00 NFE2L2 (0.56) NFE2L2RELAALOX5PTGS1PTGS2
SCHEMBL5937913 1.00 NFE2L2 (0.56) NFE2L2RELAALOX5PTGS1PTGS2
SCHEMBL5937944 1.00 NFE2L2 (0.56) NFE2L2RELAALOX5PTGS1PTGS2
SCHEMBL5492449 1.00 NFE2L2 (0.56) NFE2L2RELAALOX5PTGS1PTGS2
SCHEMBL16489726 1.00 NFE2L2 (0.56) NFE2L2RELAALOX5PTGS1PTGS2
SCHEMBL3629423 1.00 NFE2L2 (0.56) NFE2L2RELAALOX5PTGS1PTGS2
SCHEMBL10015739 1.00 NFE2L2 (0.56) NFE2L2RELAALOX5PTGS1PTGS2
SCHEMBL75905 1.00 NFE2L2 (0.56) NFE2L2RELAALOX5PTGS1PTGS2
SCHEMBL20663990 1.00 NFE2L2 (0.56) NFE2L2RELAALOX5PTGS1PTGS2
SCHEMBL75906 1.00 NFE2L2 (0.56) NFE2L2RELAALOX5PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9815997-B2 Organic electroluminescence device and ink composition IDEMITSU KOSAN CO., LTD. (JP) 2017-11-14 US disclosed
US-9815997-B2 Organic electroluminescence device and ink composition IDEMITSU KOSAN CO., LTD. (JP) 2017-11-14 US disclosed
US-9188885-B2 Reactive compound, charge transporting film, photoelectric conversion device, electrophotographic photoreceptor and method of producing the same, process cartridge, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2015-11-17 US disclosed
US-20150284580-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND INK COMPOSITION IDEMITSU KOSAN CO., LTD. (JP) 2015-10-08 US disclosed
US-20150284580-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND INK COMPOSITION IDEMITSU KOSAN CO., LTD. (JP) 2015-10-08 US disclosed
US-9005855-B2 Electrophotographic photoreceptor, process cartridge, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2015-04-14 US disclosed
US-8808952-B2 Composition for forming charge transporting film, electrophotographic photoreceptor, process cartridge, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2014-08-19 US disclosed
US-20140079435-A1 NOVEL REACTIVE COMPOUND, CHARGE TRANSPORTING FILM, PHOTOELECTRIC CONVERSION DEVICE, ELECTROPHOTOGRAPHIC PHOTORECEPTOR AND METHOD OF PRODUCING THE SAME, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJI XEROX CO., LTD. (JP) 2014-03-20 US disclosed
US-20140072906-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJI XEROX CO., LTD. (JP) 2014-03-13 US disclosed
US-8669029-B2 Reactive compound, charge transporting film, photoelectric conversion device, electrophotographic photoreceptor and method of producing the same, process cartridge, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2014-03-11 US disclosed
US-20090261714-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-10-22 US disclosed
EP-2098532-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-09-09 EP disclosed
EP-2085450-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-08-05 EP disclosed
US-20080303422-A1 Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-12-11 US disclosed
US-20080303422-A1 Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-12-11 US disclosed
US-20080001123-A1 Luminescent Ink Composition for Organic Electroluminescent Device IDEMITSU KOSAN CO., LTD (JP) 2008-01-03 US disclosed
US-20080001123-A1 Luminescent Ink Composition for Organic Electroluminescent Device IDEMITSU KOSAN CO., LTD (JP) 2008-01-03 US disclosed
US-7147938-B2 Organic element for electroluminescent devices EASTMAN KODAK COMPANY (US) 2006-12-12 US disclosed
US-20060003183-A1 Light emitting diodes with light emitting layers containing a stilbene derivative and a boron complex having an absorption spectrum that overlaps with the emission spectrum of the stilbene derivative; improved brightness EASTMAN KODAK COMPANY 2006-01-05 US disclosed
US-5480765-A PRESSURE AND HEAT SENSITIVE PAPER, IMPROVED PHOTOSTABILITY BY ADDITION OF TRIARYLAMINE COMPOUND FUJI PHOTO FILM CO., LTD. (JP) 1996-01-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090261714-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same AOX1, ODC1, LEF1 NFE2L2 83/4885RELA 3164/4885ALOX5 381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.